» Articles » PMID: 35992985

A Multi-Disciplinary Approach for the Management of Prosthetic Joint Infections: An Australian Perspective

Overview
Journal Malays Orthop J
Specialty Orthopedics
Date 2022 Aug 22
PMID 35992985
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Prosthetic joint infections (PJI) are a major complication of hip and knee arthroplasty, imposing significant morbidity and mortality. Orthopaedic oncology units have utilised a multi-disciplinary team (MDT) approach for some time. PJI is not only an equally life-threatening condition, it also requires input from multiple healthcare personnel and treatment can vary significantly between individuals given the diversity in microbiological, surgical and host factors. Our arthroplasty service established an MDT meeting to manage this complex patient group. This study describes the philosophy and implementation of an MDT approach to the management of PJIs at a tertiary hospital in Australia.

Materials And Methods: A retrospective review of all patients that presented to the MDT PJI meeting from October 2017 to April 2020 was performed. Patient characteristics, microbiological profile and management were reviewed.

Results: One hundred and one patients were reviewed over 2.5 years with a mean age of 69.2 years (SD 11.9). Patients presenting predominantly had a primary TKR (32%) or primary THR (22%). Results of Microbiology cultures varied, with 42% Gram-positive organisms, 13% Gram-negative organisms, 2% fungus and 1% yeast origin. Management mainly consisted of two-stage revision (28%), debridement-antibiotics-and-implant retention (22%) and antibiotic suppression (14%). A total of 91.5% of patients who underwent surgical management were considered cured at one year.

Conclusion: PJIs are complex and require coordinated care by a number of healthcare personnel. The MDT process has allowed collaboration between Orthopaedic, Infectious Disease and Microbiology departments and aims to improve the quality of care provided to patients, potentially reducing morbidity and mortality of patients with PJI.

Citing Articles

DAIR for periprosthetic joint infections-One week to save the joint?.

Gupta V, Shahban S, Petrie M, Kimani P, Kozdryk J, Riemer B Arthroplasty. 2024; 6(1):61.

PMID: 39633436 PMC: 11619623. DOI: 10.1186/s42836-024-00282-y.

References
1.
Zmistowski B, Karam J, Durinka J, Casper D, Parvizi J . Periprosthetic joint infection increases the risk of one-year mortality. J Bone Joint Surg Am. 2013; 95(24):2177-84. DOI: 10.2106/JBJS.L.00789. View

2.
Diaz-Ledezma C, Higuera C, Parvizi J . Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus. Clin Orthop Relat Res. 2013; 471(7):2374-82. PMC: 3676607. DOI: 10.1007/s11999-013-2866-1. View

3.
Karczewski D, Winkler T, Renz N, Trampuz A, Lieb E, Perka C . A standardized interdisciplinary algorithm for the treatment of prosthetic joint infections. Bone Joint J. 2019; 101-B(2):132-139. DOI: 10.1302/0301-620X.101B2.BJJ-2018-1056.R1. View

4.
Lamagni T . Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother. 2014; 69 Suppl 1:i5-10. DOI: 10.1093/jac/dku247. View

5.
Ibrahim M, Raja S, Khan M, Haddad F . A multidisciplinary team approach to two-stage revision for the infected hip replacement: a minimum five-year follow-up study. Bone Joint J. 2014; 96-B(10):1312-8. DOI: 10.1302/0301-620X.96B10.32875. View